Federal and state government failures resulted in preventable deaths of tens of thousands - and perhaps hundreds of thousands - of people.
How?
Heavy-handed regulation greatly increases the cost of pharmaceutical research, thereby reducing the supply of new and effective therapies.
A recent study by Tufts Center for the Study of Drug Development found that it now costs drugmakers approximately $2.6 billion - up from $802 million in 2003 - to create a new drug.
Moreover, Food and Drug Administration staffers in charge of approving COVID treatments and vaccines delayed meetings and took days off, even as the newly discovered solutions were in their hands and Americans were dying in unprecedented numbers.
Even today, health officials are unable to save lives by offering a single dose of vaccine to twice as many people despite clear evidence that one shot is highly effective.
Compare the ineptitude of government officials with the biotechs that worked at lightning speed - and with unprecedented cooperation - to bring us the vaccines we have.
As I've pointed out here before,
Moderna (Nasdaq: MRNA) created its vaccine
within two days of China posting the coronavirus genome online in January of last year.
And while public officials warn us to gird ourselves for the next pandemic, Ronald Bailey - one of the best science writers in America (and a keynote speaker at our Investment U Conference in St. Petersburg, Florida, last month) - points out in the latest issue of
Reason magazine that this may be the last one.
Why? Because science - and business - has gotten
that good.
Big Pharma isn't just making new vaccines. It's making them in an entirely new way.
Previously, most vaccines were based on weakened or genetically modified viruses.
But messenger RNA (mRNA) vaccines are different. They are essentially sets of instructions that direct cells in the body to make proteins that prevent or fight disease.
The commercialization of mRNA vaccines - for a host of illnesses - has only just begun.
But that's not the only reason the next outbreak should get nipped in the bud before it ever becomes a pandemic.
As Bailey points out...
The greatly speeded-up biomedical innovation provoked by the current global scourge has provided future generations with tools to keep subsequent viral invasions at bay. These include fast new vaccine production platforms, the development of better diagnostic and disease surveillance monitoring, and progress in the rapid design of therapeutics.
Advances in genetic sequencing, biologics and vaccine development are helping create new medicines in record time.